Amoxicillin, metronidazole and tetracycline (DrugBank: Tetracycline, Metronidazole, Amoxicillin)
9 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
6 | Parkinson disease | 0 |
19 | Lysosomal storage disease | 0 |
46 | Malignant rheumatoid arthritis | 0 |
63 | Idiopathic thrombocytopenic purpura | 0 |
84 | Sarcoidosis | 0 |
96 | Crohn disease | 0 |
97 | Ulcerative colitis | 1 |
222 | Primary nephrotic syndrome | 0 |
299 | Cystic fibrosis | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03986996 (ClinicalTrials.gov) | July 2019 | 4/6/2019 | Antimicrobial Therapy for Ulcerative Colitis (UC) | Antimicrobial Therapy for Ulcerative Colitis : Evaluation of Two Antibiotic Combinations for Refractory Ulcerative Colitis | Ulcerative Colitis | Drug: amoxicillin, metronidazole and tetracycline;Drug: amoxicillin and tetracycline | Wolfson Medical Center | NULL | Not yet recruiting | 13 Years | 60 Years | All | 40 | Phase 2 | Israel |